SCHEMBL20111022

SCHEMBL20111022

Cc1coc2c1ccc1c3ccc4c(C)coc4c3ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.38
▸ CES1 P23141 2/20 0.37
▸ MAPT P10636 2/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ KCNA3 P22001 6/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ TSHR P16473 3/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ MAOB P27338 1/20 0.31
▸ MGAM O43451 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ SI P14410 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ MCL1 Q07820 1/20 0.31
▸ MGAM2 Q2M2H8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12279309 1.00 HSD17B10 (0.38) HSD17B10CES1MAPTCREBBPSMN1; SMN2
SCHEMBL4419414 0.89 CES1 (0.39) HSD17B10CES1MAPTSMN1; SMN2KCNA3
SCHEMBL20793964 0.80 SMN1; SMN2 (0.53) HSD17B10CES1MAPTSMN1; SMN2KCNA3
SCHEMBL20793965 0.77 SMN1; SMN2 (0.35) HSD17B10CES1SMN1; SMN2KCNA3ALDH1A1
SCHEMBL2607400 0.75 CYP2A6 (0.48) CES1MAPTSMN1; SMN2KCNA3ALDH1A1
SCHEMBL21387019 0.75 SMN1; SMN2 (0.38) HSD17B10CES1SMN1; SMN2KCNA3KDM4E
SCHEMBL20793963 0.75 KCNA3 (0.42) HSD17B10CES1MAPTSMN1; SMN2KCNA3
SCHEMBL14444123 0.75 AHR (0.39) HSD17B10CES1MAPTSMN1; SMN2KCNA3
SCHEMBL6305348 0.72 KCNA3 (0.39) HSD17B10CES1KCNA3
SCHEMBL4430661 0.72 ATM (0.35) HSD17B10CES1SMN1; SMN2KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180122585-A1 PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL USING THE SAME FUJIFILM CORPORATION (JP) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180122585-A1 PHOTOELECTRIC CONVERSION ELEMENT, AND SOLAR CELL USING THE SAME SUN2, SLC9A2, SLC43A3 HSD17B10 3315/4885CES1 3381/4885MAPT 2375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback